When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Premenstrual syndrome and dysphoric disorder

Última revisão: 5 Aug 2025
Última atualização: 08 Feb 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • abdominal bloating
  • fatigue
  • breast tenderness
  • headaches
  • depressed mood, irritability, and internal tension
  • labile mood
  • adverse effect on life
Detalhes completos

Outros fatores diagnósticos

  • increased appetite
  • forgetfulness and difficulty concentrating
  • other subjective symptoms
  • insomnia or hypersomnia
  • gastrointestinal upset
  • heart palpitations
  • hot flashes
Detalhes completos

Fatores de risco

  • postpubescent and premenopausal women
  • family history
  • mood disorders
  • cigarette smoking
  • white women
  • sexual abuse and/or trauma
  • alcohol consumption
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • prospective symptom diary
Detalhes completos

Investigações a serem consideradas

  • thyroid function tests
  • follicle-stimulating hormone levels
  • depression screening
  • CBC
Detalhes completos

Algoritmo de tratamento

CONTÍNUA

mild PMS

moderate to severe PMS or PMDD

Colaboradores

Autores

Nancy A. Phillips, MD

Associate Professor

Department of Obstetrics, Gynecology and Reproductive Sciences

Rutgers Robert Wood Johnson Medical School

New Brunswick

NJ

Declarações

NAP has been reimbursed by Synexis Pharma, manufacturer of Ibrexafungerp, for attending advisory boards. NAP is on the North American Board of the North American chapter of the ISSVD (International Society for the Study of Vulvovaginal Disease). NAP has received grants from Syneos for a study on Myfembree.

Gloria Bachmann, MD

Professor

Department of Obstetrics, Gynecology and Reproductive Sciences

Rutgers Robert Wood Johnson Medical School

New Brunswick

NJ

Declarações

GB declares that she has no competing interests.

Agradecimentos

Dr Nancy A. Phillips and Dr Gloria Bachmann would like to gratefully acknowledge Professor Margaret Rees and Dr Desiree Lie, the previous contributors to this topic.

Declarações

MR and DL declare that they have no competing interests.

Revisores

Julianne Toohey, MD

Obstetrician-Gynecologist

Department of Obstetrics and Gynecology

University of California Irvine Medical Center

Orange

CA

Declarações

JT declares that she has no competing interests.

Carol Henshaw, MB ChB, MD

Consultant in Perinatal Mental Health

Liverpool Women's NHS Foundation Trust

Liverpool

UK

Declarações

CH declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

American College of Obstetricians and Gynecologists. ACOG clinical practice guideline no. 7: management of premenstrual disorders. Dec 2023 [internet publication].Texto completo

Ismaili E, Walsh S, O'Brien PMS, et al; Consensus Group of the International Society for Premenstrual Disorders. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016 Dec;19(6):953-8. Resumo

Green LJ, O’Brien PMS, Panay N, et al; Royal College of Obstetricians and Gynaecologists. Management of premenstrual syndrome: green-top guideline no. 48. BJOG. 2017 Feb;124(3):e73-105.Texto completo  Resumo

World Health Organization. International classification of diseases 11th revision. Jan 2022 [internet publication].Texto completo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Diagnósticos diferenciais

    • Depression
    • Thyroid disease
    • Generalized anxiety disorder
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Management of premenstrual disorders
    • Management of premenstrual syndrome
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Premenstrual syndrome

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal